Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

OptiNose Inc (OPTN)

  • Event
  • July 08, 2022, 11:00 UTC
  • 8
  • 1 comments

(75% Positive) OPTINOSE, INC. (OPTN) Provides Update on deep for chronic

Comment Full text

Legend Biotech (LEGN)

  • Event
  • July 07, 2022, 12:31 UTC
  • 8
  • 1 comments

(10% Negative) Legend Biotech (LEGN) Announces Clinical Development Update (Form 6-K)

Comment Full text

Guardant Health Inc (GH)

  • Event
  • July 07, 2022, 12:08 UTC
  • 11
  • 1 comments

(99% Neutral) GUARDANT HEALTH, INC. (GH) Files Form 8-K

Comment Full text

Intercept Pharmaceuticals Inc (was acquisited by Alfasigma (Italy) on 08/11/2023) (ICPT)

  • Event
  • July 07, 2022, 11:30 UTC
  • 11
  • 1 comments

(10% Negative) Intercept Pharmaceuticals, Inc. (ICPT) Announces Delay in announced Trials for OCA in liver fibrosis due to NASH Due to Pandemic-Related Challenges, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

Comment Full text

Abcellera Biologics Inc (ABCL)

  • Event
  • July 06, 2022, 20:57 UTC
  • 11
  • 1 comments

(50% Neutral) ABCELLERA BIOLOGICS INC. (ABCL) Announces Executive Departure

Comment Full text

CytomX Therapeutics Inc (CTMX)

  • Event
  • July 06, 2022, 20:10 UTC
  • 11
  • 1 comments

(85% Positive) CYTOMX THERAPEUTICS, INC. (CTMX) Announces Clinical Development Update

Comment Full text

Genmab (GMAB)

  • Event
  • July 06, 2022, 13:06 UTC
  • 10
  • 1 comments

(99% Neutral) Genmab (GMAB) Files Form 6-K

Comment Full text

Applied Molecular Transport Inc (merged with Cyclo Therapeutics (CYTH)) (AMTI)

  • Event
  • July 06, 2022, 12:01 UTC
  • 11
  • 1 comments

(70% Positive) APPLIED MOLECULAR TRANSPORT INC. (AMTI) Announces Clinical Development Update

Comment Full text

Passage Bio Inc (PASG)

  • Event
  • July 06, 2022, 11:00 UTC
  • 11
  • 1 comments

(99% Neutral) PASSAGE BIO, INC. (PASG) Announces New Board Appointment

Comment Full text

HUTCHMED DRC (HCM)

  • Event
  • July 06, 2022, 10:15 UTC
  • 10
  • 1 comments

(75% Positive) HUTCHMED DRC (HCM) Announces Clinical Development Update (Form 6-K)

Comment Full text
  • Previous
  • 164
  • 165
  • 166
  • 167
  • 168
  • Next

Search

News categories

  • Technical Exchange News(10870)
  • Event(2243)
  • SEC News(189155)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124509)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin